search
Back to results

Optimizing the Diagnosis of Acute Appendicitis (OPTIMA)

Primary Purpose

Acute Appendicitis

Status
Unknown status
Phase
Not Applicable
Locations
Lithuania
Study Type
Interventional
Intervention
Observation
Sponsored by
Vilnius University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Acute Appendicitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient with the symptoms of acute appendicitis: pain in the right lower quadrant, pain migration from epigastrium to right lower quadrant, nausea, rebound pain, elevated temperature.

Exclusion Criteria for randomized part:

  • Pregnant patient.

Inclusion Criteria for randomized part:

  • After primary clinical, laboratory and ultrasound examination diagnosis of acute appendicitis could not be confirmed or excluded.
  • No other gynecological, urological ir gastroenterological pathology is confirmed.

Exclusion Criteria for randomized part:

  • Clinical symptoms lasts for longer than 48 hours
  • Signs of peritonitis

Sites / Locations

  • Faculty of medicine, Institue of clinical medicine, Clinic of gastroenterology, nephrourology and surgeryRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Control

Observation

Arm Description

Patient gets usual diagnostic path: after inconclusive ultrasound is refered to CT scan.

Patient after inconclusive primary evaluation is observed in emergency room for 8-12 hours and after the clinical evaluation, laboratory results and ultrasound examination is repeated.

Outcomes

Primary Outcome Measures

Reduction of the CT scans number
when performing alternative diagnostic protocol, that includes patient observation for short period we expect to reduce a number of CT scans performed, for the patients with suspected acute appendicitis.
Negative appendectomy rate
We expect the negative appendectomy rate will will not increase while using alternative diagnostic protocol that includes patient observation.

Secondary Outcome Measures

Delta marker White blood cell count
The changes in white blood cell count over the time that might show higher or lower probability of possible acute appendicitis.
Delta marker CRP count
The changes CRP level over the time that might show higher or lower probability of possible acute appendicitis.
Delta marker Alvarado acute appendicitis risk evaluation score
Delta marker Alvarado acute appendicitis risk evaluation score Tha changes in score over the time that might show higher or lower probability of possible acute appendicitis. Scale ranges decribe a prediction of having acute appendicitis: 1-4 33 % of having appendicitis, 5-6 66 % of hanving, 7-10 93 % of having appendicitis.
Delta marker changes in ultrasound results
The changes in ultrasound findings over the time may progress and influence investigator to change opinion about the concusion. Repeated ultrasound diagnosis might change from unequivocal to acute apendicitis (and CT scan can be avoided then). We do use structured conclusions of the ultrasound exam, that might be: accute appendicitis; apendix visualised but changes are equivocal; apendix visualised uninflamed; apendix not visualised, but there are secondary findings; apendix not visualised and there is no secondary findings. We are going to measure the change in final ultrasound diagnosis over the time.
'Appendicitis Inflammatory Response (AIR) Score'
'Appendicitis Inflammatory Response (AIR) Score') evaluates the risk for acute appendicitis. scale ranges are: 0-4 low probability outpatient follow up, 5-8 inermediate probability in hospital observation, 9-12 high probability, surgical treatment..

Full Information

First Posted
June 29, 2019
Last Updated
October 3, 2019
Sponsor
Vilnius University
search

1. Study Identification

Unique Protocol Identification Number
NCT04117061
Brief Title
Optimizing the Diagnosis of Acute Appendicitis
Acronym
OPTIMA
Official Title
Optimizing the Diagnosis of Acute Appendicitis - Open, Randomized, Parallel Groups, Prospective Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
December 1, 2018 (Actual)
Primary Completion Date
January 1, 2021 (Anticipated)
Study Completion Date
May 1, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vilnius University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Aim of the study: to identify the signs of acute appendicitis delta signs - clinical, laboratory or ultrasound signs, whose change (delta) would allow to identify or deny the diagnosis of acute appendicitis without a computed tomography examination and thus to lower computed tomography rates.
Detailed Description
This study consists of two parts: In the first part investigators enroll all patients (except pregnant) that are refered to Vilnius University Hospital Santaros clinics with suspected acute appendicitis in order to get cohort data. All patient get primary clinical evaluation, laboratory tests (WBC, CRP) an ultrasound examination. After primary evaluation if final diagnosis could not be made, and investigator still suspect acute appendicitis, participant is included in to randomised study part. Randomised sudy part has two arms: control and observation groups. Control group get the traditional diagnostic path - is refered to CT scan examination. Observation group get repeated evaluation after 8-12 hours and only than is diagnosis stays unclear, patient gets a CT scan. All patient are contacted after 30 days after visit to our hospital, to get information about their health status and possible additional visits to other hospitals or operations.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Appendicitis

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Open, randomized, parallel groups prospective study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Patient gets usual diagnostic path: after inconclusive ultrasound is refered to CT scan.
Arm Title
Observation
Arm Type
Active Comparator
Arm Description
Patient after inconclusive primary evaluation is observed in emergency room for 8-12 hours and after the clinical evaluation, laboratory results and ultrasound examination is repeated.
Intervention Type
Procedure
Intervention Name(s)
Observation
Intervention Description
Patient after primary investigation is observed for 8-12 hours, (instead of being send directly to CT scan), after observation repeated clinical evaluation, laboratory tests and ultrasound examination are done , if final diagnosis stays unclear the patient is refered to CT scan.
Primary Outcome Measure Information:
Title
Reduction of the CT scans number
Description
when performing alternative diagnostic protocol, that includes patient observation for short period we expect to reduce a number of CT scans performed, for the patients with suspected acute appendicitis.
Time Frame
24 hours
Title
Negative appendectomy rate
Description
We expect the negative appendectomy rate will will not increase while using alternative diagnostic protocol that includes patient observation.
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Delta marker White blood cell count
Description
The changes in white blood cell count over the time that might show higher or lower probability of possible acute appendicitis.
Time Frame
12 hours
Title
Delta marker CRP count
Description
The changes CRP level over the time that might show higher or lower probability of possible acute appendicitis.
Time Frame
12 hours
Title
Delta marker Alvarado acute appendicitis risk evaluation score
Description
Delta marker Alvarado acute appendicitis risk evaluation score Tha changes in score over the time that might show higher or lower probability of possible acute appendicitis. Scale ranges decribe a prediction of having acute appendicitis: 1-4 33 % of having appendicitis, 5-6 66 % of hanving, 7-10 93 % of having appendicitis.
Time Frame
12 hours
Title
Delta marker changes in ultrasound results
Description
The changes in ultrasound findings over the time may progress and influence investigator to change opinion about the concusion. Repeated ultrasound diagnosis might change from unequivocal to acute apendicitis (and CT scan can be avoided then). We do use structured conclusions of the ultrasound exam, that might be: accute appendicitis; apendix visualised but changes are equivocal; apendix visualised uninflamed; apendix not visualised, but there are secondary findings; apendix not visualised and there is no secondary findings. We are going to measure the change in final ultrasound diagnosis over the time.
Time Frame
12 hours
Title
'Appendicitis Inflammatory Response (AIR) Score'
Description
'Appendicitis Inflammatory Response (AIR) Score') evaluates the risk for acute appendicitis. scale ranges are: 0-4 low probability outpatient follow up, 5-8 inermediate probability in hospital observation, 9-12 high probability, surgical treatment..
Time Frame
12 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient with the symptoms of acute appendicitis: pain in the right lower quadrant, pain migration from epigastrium to right lower quadrant, nausea, rebound pain, elevated temperature. Exclusion Criteria for randomized part: Pregnant patient. Inclusion Criteria for randomized part: After primary clinical, laboratory and ultrasound examination diagnosis of acute appendicitis could not be confirmed or excluded. No other gynecological, urological ir gastroenterological pathology is confirmed. Exclusion Criteria for randomized part: Clinical symptoms lasts for longer than 48 hours Signs of peritonitis
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tomas Poskus, Professor.
Phone
+37068678893
Email
tomas.poskus@santa.lt
First Name & Middle Initial & Last Name or Official Title & Degree
Raminta Luksaite, Phd student
Phone
+37068960611
Email
raminta.luksaite@santa.lt
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tomas Poskus, Professor
Organizational Affiliation
Vilnius University, Faculty of medicine, Institute of clinical medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of medicine, Institue of clinical medicine, Clinic of gastroenterology, nephrourology and surgery
City
Vilnius
Country
Lithuania
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tomas Poskus, Professor
Phone
+37068678893
Email
tomas.poskus@santa.lt

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There are no future intensions make IPD available.

Learn more about this trial

Optimizing the Diagnosis of Acute Appendicitis

We'll reach out to this number within 24 hrs